SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001072613-18-000085
Filing Date
2018-02-05
Accepted
2018-02-05 16:20:37
Documents
1
Group Members
ALEXANDRA GOLLHELMUT SCHUHSLERHUBERT BIRNERSTEFAN FISCHERTVM LIFE SCIENCE VENTURES MANAGEMENT VI L.P.TVM LIFE SCIENCE VENTURES VI L.P.

Document Format Files

Seq Description Document Type Size
1 TVM LIFE SCIENCE VENTURES VI GMBH & CO KG / CONCERT PHARMACEUTICALS, INC. - SCHE tvm-concert_13ga18161.htm SC 13G/A 64018
  Complete submission text file 0001072613-18-000085.txt   65876
Mailing Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Subject) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88033 | Film No.: 18574431
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TVM CAPITAL GROUP OTTOSTRASSE 4 MUNICH 2M 80333
Business Address C/O TVM CAPITAL GROUP OTTOSTRASSE 4 MUNICH 2M 80333 49 89 998 992-0
TVM Life Science Ventures VI GmbH & Co KG (Filed by) CIK: 0001599744 (see all company filings)

IRS No.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: SC 13G/A